Skip to main content
OpenTrials

Clinical trial condition

Immune Thrombocytopenia

Explore clinical trials studying Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

94 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Immune Thrombocytopenia trial results

Completed

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

NCT01444417

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +20 more
Locations
  • Research Site Orange, California, United States
  • Research Site San Diego, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Atlanta, Georgia, United States
View all 33 locations
View Trial Details
Completed

An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia

NCT02063789

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Chungnam National University Hospital Daejeon, South Korea
  • Daegu Catholic University Medical Center Deagu, South Korea
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Gachon University Gil Medical Center Incheon, South Korea
View all 14 locations
View Trial Details
Active, Not Recruiting

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

NCT05757570

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +22 more
Locations
  • Investigational Site (230) Los Angeles, California, United States
  • Investigational Site (401) Washington D.C., District of Columbia, United States
  • Investigational Site (419) Cooper City, Florida, United States
  • Investigational Site (425) Miami, Florida, United States
View all 44 locations
View Trial Details

Related conditions